DLX2 was demonstrated to be associated with EMT in osteosarcoma in previous studies and its increased expression was associated with advanced gastric adenocarcinoma, but no article defining the relationship between DLX2 and poor prognosis in colorectal cancer could be found yet (102, 103). The gene discussed is DLX2; the disease is gastric adenocarcinoma.